返回
Redundancy in two major compound databases
DOI:10.1016/j.drudis.2018.03.005.png)
摘要
En 中文
Public repositories of compounds and activity data are of prime importance for pharmaceutical research in academic and industrial settings. Major databases have evolved over the years. Their growth is accompanied by an increasing tendency toward data sharing. This is a positive development but not without potential problems. Using ChEMBL and PubChem as examples, we show that crosstalk between databases also leads to substantial data redundancy that might not be obvious. Redundancy is an important issue because it biases data analysis and knowledge extraction and leads to inflated views of available compounds, assays and activity data. Going forward it will be important to further refine data exchange and deposition criteria and make redundancy as transparent as possible.
Keyword:
OPEN INNOVATION
CHEMBL
BINDINGDB
ZINC
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
7.5
论文数:
6.4K
被引数:
2.3W
机构
引用论文
BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacologyBindingDB 2015年: 药物化学,计算化学和系统药理学的公共数据库
NUCLEIC ACIDS RESEARCH
IF13.1
ZINC - A free database of commercially available compounds for virtual screening锌-用于虚拟筛选的市售化合物的免费数据库

